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Abstract 26 
Ferritins are a large family of intracellular proteins that protect the cell from oxidative stress by 27 
catalytically converting Fe(II) into less toxic Fe(III) and storing iron minerals within their core. 28 
Encapsulated ferritins (EncFtn) are a sub-family of ferritin-like proteins, which are widely distributed 29 
in all bacterial and archaeal phyla. The recently characterized Rhodospirillum rubrum EncFtn 30 
displays an unusual structure when compared to classical ferritins, with an open decameric structure 31 
that is enzymatically active, but unable to store iron. This EncFtn must be associated with an 32 
encapsulin nanocage in order to act as an iron store. Given the wide distribution of the EncFtn family 33 
in organisms with diverse environmental niches, a question arises as to whether this unusual 34 
structure is conserved across the family. Here, we characterize EncFtn proteins from the 35 
halophile Haliangium ochraceum and the thermophile Pyrococcus furiosus, which show the 36 
conserved annular pentamer of dimers topology. Key structural differences are apparent between 37 
the homologues, particularly in the centre of the ring and the secondary metal binding site, which is 38 
not conserved across the homologues. Solution and native mass spectrometry analyses highlight 39 
that the stability of the protein quaternary structure differs between EncFtn proteins from different 40 
species. The ferroxidase activity of EncFtn proteins was confirmed, and we show that while the 41 
quaternary structure around the ferroxidase centre is distinct to classical ferritins, the ferroxidase 42 
activity is still inhibited by Zn(II). Our results highlight the common structural organization and activity 43 
of EncFtn proteins, despite diverse host environments and contexts within encapsulins. 44 
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Introduction 46 
The encapsulated ferritins (EncFtn) are recently described members of the ferritin superfamily [1–47 
3]. These proteins are sequestered within encapsulin nanocompartments, and the two proteins act 48 
in concert to provide an iron storage system with a much greater capacity than the classical ferritins 49 
and DNA-binding Protein from Starved cells (DPS) nanocages [3,4]. Genes encoding encapsulin-50 
associated ferritins have been identified in a wide range of bacterial and archaeal species that inhabit 51 
diverse ecological niches from ponds, streams (Rhodospirillum rubrum), and coastal seas 52 
(Haliangium ochraceum), to abyssal ocean vents (Pyrococcus furiosus) [5].  53 
The R. rubrum EncFtn was the first protein in its family to be structurally and biochemically 54 
characterized; it has a fold with two antiparallel alpha-helices that adopts an annular-decamer 55 
quaternary structure, assembled as a pentamer of dimers [1]. The subunits dimerize through metal-56 
mediated contacts to reconstitute the four-helix ferritin fold with a functional ferroxidase centre [6,7]. 57 
While the EncFtn protein displays ferroxidase activity, it is not capable of storing iron in the same 58 
way as other ferritins due to its open architecture and the lack of an enclosed cavity for iron 59 
mineralization [8,9]; therefore, EncFtn family proteins must be localized to the interior of an 60 
encapsulin nanocage for efficient iron storage [1,3,5]. Localization to encapsulin nanocages is 61 
mediated by a short encapsulation sequence, which is usually appended to the C-terminus of the 62 
EncFtn protein chain [1,3,5,10]; addition of this sequence to heterologous proteins is sufficient to 63 
direct them to the lumen of encapsulins [11,12].  64 
The encapsulin protein family is structurally related to the HK97 bacteriophage shell protein and they 65 
form icosahedral nanocages of between 25 and 35 nm in diameter. Pores are formed at the 66 
icosahedral symmetry axes between subunits to allow substrate access to encapsulated enzyme 67 
cargoes [3,5,10,13]. The R. rubrum encapsulin was shown to associate with over 2000 iron ions per 68 
capsid, while being catalytically inactive; and, in concert with EncFtn, capable of mineralizing and 69 
storing more than four times as much iron as a classical ferritin nanocage [1]. Given the wide 70 
distribution of encapsulin proteins across bacterial and archaeal phyla, and the conservation of the 71 
EncFtn proteins in 20 % of all phyla with encapsulin genes, we investigated the structure and activity 72 
of EncFtn proteins from the halophilic Proteobacterium H. ochraceum and the EncFtn-fusion from 73 
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the Euryarchaeota P. furiosus, to determine whether the structural and functional organization seen 74 
in the R. rubrum EncFtn is conserved within its phylum and between domains and environmental 75 
niches. 76 
Here we report the structural and biochemical characterization of members of the EncFtn family from 77 
H. ochraceum and P. furiosus. Both proteins adopt similar topology to the R. rubrum EncFtn and 78 
assemble as annular decamers formed from pentamers of dimers, with ferroxidase centres located 79 
at one of the dimer interfaces. The ferroxidase activities of the proteins are comparable, and they 80 
show similar levels of inhibition by the competing metal ion zinc. These data show that the structural 81 
and biochemical features of encapsulated ferritins are conserved across different environmental 82 
niches and phyla with particular adaptations for thermal stability in thermophilic microorganisms. 83 
  84 
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Materials and Methods 85 
Cloning expression and purification of EncFtn and EncFtn homologues 86 
Recombinant encapsulated ferritin from Rhodospirillum rubrum was produced as described 87 
previously [1]. DNA fragments encoding truncated versions of the encapsulated ferritins from 88 
Haliangium ochraceum (Hoch_38361-98) (Uniprot: D0LZ73_HALO1) and Pyrococcus furiosus 89 
(Pfc_015751-99) (Uniprot: I6U7J4_9EURY) were produced as double-stranded gBlocks (IDT) and 90 
codon optimized for expression in E. coli, with restriction endonuclease sites for insertion into pET-91 
28a (Pfc_051571-99) or a modified pET-28 vector with CIDAR MoClo [14] Golden Gate cloning sites 92 
(Hoch_38361-98). Untagged and His-tagged variants were produced for both proteins in this way. A 93 
StrepII-tagged variant of each protein was produced by assembly of the EncFtn gBlock into a CIDAR 94 
MoClo destination vector with a custom T7 promoter and StrepII-tag terminator part. Sequences of 95 
primers and gBlocks used in this study are shown in Tables S1 and S2 respectively, and the 96 
sequences of expressed proteins are shown in Table S3. The expression plasmids were transformed 97 
into E. coli BL21(DE3) cells and a single colony was grown overnight at 37 °C in 100 ml LB medium, 98 
supplemented with 35 µg/ml kanamycin, with shaking at 180 rpm. The cells were sub-cultured into 99 
1 L of LB or M9 minimal medium, grown until OD600=0.6, and protein production was induced with 100 
1 mM IPTG, the temperature was reduced to 18 °C and cells were incubated for a further 18 hours.  101 
Cells were harvested by centrifugation at 4,000 × g and washed with PBS. Cell-free extract was 102 
produced by resuspending cells in 10 x v/w Buffer A (50 mM Tris-HCl, pH 8.0) and sonicated on ice 103 
for 5 minutes with 30 s on/off cycle at 60 watts power output. The lysate was cleared by centrifugation 104 
at 35,000 × g and filtered with a 0.45 µm syringe filter. Untagged recombinant proteins were purified 105 
from cell-free extract by anion exchange using HiPrep Q sepharose fast-flow 16/10 column (GE 106 
Healthcare) equilibrated with Buffer A. Cell free extract was applied to the column and unbound 107 
proteins were washed off with 10 column volumes of Buffer A. Proteins were eluted with a linear 108 
gradient of Buffer B (50 mM Tris-HCl, pH 8.0, 1 M NaCl) over 20 column volumes and fractions 109 
collected.  110 
His-tagged proteins were purified by resuspending cells in 10 x (v/w) Buffer HisA (50 mM Tris-HCl, 111 
pH 8.0, 500 mM NaCl, 50 mM imidazole) before sonication and clarification as above. Clarified cell 112 
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lysate was applied to a 5 ml HisTrap FF column (GE Healthcare) and unbound proteins were washed 113 
off with 10 column volumes of Buffer HisA. A step-gradient of 50 % and 100 % Buffer HisB (50 mM 114 
Tris-HCl, pH 8.0, 500 mM NaCl, 500 mM imidazole) was used to elute His-tagged proteins.   115 
Fractions of Q sepharose or His-trap eluent containing the protein of interest, as identified by 15 % 116 
(w/v) SDS-PAGE, were subjected to size-exclusion chromatography using an S200 16/60 column, 117 
previously calibrated with LMW/HMW calibration kits (GE Healthcare) (Fig. S1) and equilibrated with 118 
Buffer GF (50 mM Tris-HCl, pH 8.0, 150 mM NaCl). 119 
StrepII-tagged proteins were purified by suspending cells in 10 x (v/w) Buffer W (100 mM Tris pH 120 
8.0, 150 mM NaCl) before sonication and clarification as described above. Cell lysate was applied 121 
to Strep-Trap HP column (GE Healthcare), prepared as suggested by the manufacturer, and 122 
unbound proteins were washed off by applying 5 column volumes of Buffer W. Strep-tagged proteins 123 
were eluted by Buffer E (100 mM Tris pH 8.0, 150 mM NaCl, 2.5 mM desthiobiotin). Eluted protein 124 
was buffer-exchanged to Buffer GF by centrifugal concentrator Vivaspin Turbo (Sartorius, 10 kDa 125 
MWCO) to remove desthiobiotin. 126 
Protein quantification 127 
Purified protein concentration was determined by colorimetric technique using the PierceTM BCA 128 
protein assay kit following manufacturer specifications for the standard Test-tube procedure at 37 129 
°C. Diluted bovine serum albumin (BSA) standards were prepared in GF buffer. Fig. S2A/B show 130 
colour response curves prepared for His-tagged or Strep-tagged protein quantification, respectively. 131 
Protein samples absorbance at 562 nm (average of 3 experimental replicates) are listed in Table 132 
S4. 133 
Ferroxidase assays 134 
Ferroxidase activity of the enzymes was tested by following the formation of Fe(III) species by UV-135 
visible spectroscopy at 20 °C, as previously described [1]. Oxygen-free aliquots of Fe(II) (1 mM) 136 
were prepared by dissolving FeSO4.7H2O in 0.1 % (v/v) HCl under anaerobic conditions. Purified 137 
proteins (decameric fraction) were diluted anaerobically to the final concentration of 10 µM monomer 138 
in Buffer H (10 mM HEPES pH 8.0, 150 mM NaCl). Protein and Fe(II) samples were added to a 139 
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quartz cuvette (Hellma) under aerobic conditions at the final concentration of 10 and 50 µM, 140 
respectively. Absorbance at 315 nm was monitored every second over 1500 s using a UV-visible 141 
spectrophotometer (Perkin Elmer Lambda 35) using the provided TimeDrive software. A negative 142 
control was performed by monitoring the progress curve at A315 of Fe(II) salt sample in the absence 143 
of protein. Data presented here are the mean of three technical replicates of time zero-subtracted 144 
progress curves with standard deviations calculated from the mean. 145 
Zinc inhibition of ferroxidase activity 146 
In order to test enzyme selectivity toward Fe(II), the ferroxidase assay was carried out as previously 147 
described [1], in the presence of FeSO4.7H2O (50 µM) and various concentrations of ZnSO4.2H2O. 148 
The A315 nm progress curve of protein mixed with the highest concentration of Zn(II) used in the 149 
assay (100 µM) was also monitored as a negative control. 150 
Protein Crystallography 151 
Hoch_EncFtn and Pfc_EncFtn were concentrated to 10 mg/ml using a 10 kDa MWCO centrifugal 152 
concentrator (Vivaspin) and subjected to sitting drop vapor diffusion crystallization using 70 µl well 153 
solution and drops of 100 nl protein, plus 100 nl well solution. Crystals of Hoch_EncFtn grew in well 154 
solution containing 0.2 M NaCl, 0.1 M Bis-Tris, pH 5.5, 20 % (w/v) PEG 3350; and crystals of 155 
Pfc_EncFtn were found in a condition containing 0.2 M LiSO4.H2O, 20 % (w/v) PEG 3350. Crystals 156 
were harvested using a LithoLoop (Molecular Dimensions Limited), transferred to a cryoprotection 157 
solution of well solution supplemented with 20 % (v/v) PEG 200 and flash cooled in liquid nitrogen. 158 
Diffraction data were collected at Diamond Light Source at 100 K using a Pilatus 6M detector. Images 159 
were integrated and scaled using XDS [15]; the correct crystallographic symmetry group was 160 
confirmed with Pointless [16] and reflections were merged with Aimless [17]. The data were phased 161 
by molecular placement using Phaser, with a decamer of Rru_EncFtn (PDB ID: 5DA5) used as the 162 
search model [1]. This has 58 and 22 % sequence identity to the Hoch_EncFtn and Pfc_EncFtn 163 
respectively. The sequences were aligned with the 5DA5 protein sequence using ClustalOmega and 164 
the alignment was used to edit the search model to match the target sequence using CHAINSAW 165 
[18]. The crystallographic models were rebuilt using phenix.autobuild [19] and subsequently refined 166 
using phenix.refine [20] with cycles of manual model building in Coot [21]. The model quality was 167 
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assessed using MolProbity [22]. All structural figures were generated using PyMOL 168 
(www.pymol.org). X-ray data collection and refinement statistics are shown in Table 1. 169 
Sequence alignment and depiction 170 
The protein sequences for Hoch_3836 and the encapsulated ferritin domain of Pfc_05175 were 171 
aligned against Rru_A0973 using Clustal Omega [23] and rendered using ESPript 3.0 [24].  172 
Mass spectrometry 173 
All mass spectrometry (MS) experiments were performed on a Synapt G2 ion-mobility equipped Q-174 
ToF instrument (Waters Corp., Manchester, UK). LC-MS experiments were performed using an 175 
Acquity UPLC equipped with a reverse phase C4 Aeris Widepore 50 × 2.1 mm HPLC column 176 
(Phenomenex, CA, USA) and a gradient of 5–95% acetonitrile (0.1% formic acid) over 10 minutes 177 
was employed. For LC-MS, samples were typically analysed at 5 μM, and data analysis was 178 
performed using MassLynx v4.1 and MaxEnt deconvolution. For native MS analysis, all protein 179 
samples were buffer exchanged into 100 mM ammonium acetate (pH 8.0, or pH 5.0) using Micro 180 
Biospin Chromatography Columns (Bio-Rad, UK) prior to analysis and the resulting protein samples 181 
were analysed at a typical final concentration of ~5 µM (oligomer concentration). For native MS 182 
ionization, nano-ESI was employed using a nanomate nanoelectrospray infusion robot (Advion 183 
Biosciences, Ithaca, NY). Instrument parameters were tuned to preserve non-covalent protein 184 
complexes and were consistent for the analysis of all protein homologues. After the native MS 185 
optimization, parameters were: nanoelectrospray voltage 1.60 kV; sample cone 100 V; extractor 186 
cone 0 V; trap collision voltage 4 V; source temperature 60 °C; and source backing pressure 6.0 187 
mbar.  188 
ICP-MS 189 
Inductively coupled plasma mass spectrometry experiments were performed on samples of Rru_His, 190 
Hoch_His, and Pfc_His from size-exclusion chromatography experiments and Rru_StrepII, 191 
Hoch_StrepII, and Pfc_StrepII from the affinity chromatography purification step as described 192 
previously [1]. 193 
 194 
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Results 195 
Purification of encapsulated ferritins from H. ochraceum and P. furiosus 196 
The encapsulated ferritins from H. ochraceum and P. furiosus share 18 % amino acid sequence 197 
identity with each other, and 58 % and 22 % with the R. rubrum EncFtn (respectively referred to as 198 
Hoch_EncFtn, Pfc_EncFtn, and Rru_EncFtn herein). Residues shown to be in the ferroxidase centre 199 
of the Rru_EncFtn protein are strictly conserved in the Hoch_EncFtn and Pfc_EncFtn proteins, with 200 
secondary metal binding sites conserved in Hoch_EncFtn, but not in Pfc_EncFtn (Fig. S3).  201 
To explore the structure and function of encapsulated ferritins from different species, we produced 202 
examples of this protein family from H. ochraceum and P. furiosus as truncated variants, lacking the 203 
C-terminal encapsulin localization sequence, by heterologous expression in Escherichia coli. The H. 204 
ochraceum EncFtn was produced as a C-terminal His-tagged variant, C-terminal StrepII-tagged 205 
variant, and an untagged variant comprising residues 1-98 of the native polypeptide. In P. furiosus 206 
the encapsulated ferritin forms a single contiguous polypeptide with the encapsulin shell protein; 207 
therefore, a truncated version with residues 1-99 encompassing just the EncFtn domain was 208 
produced as both a C-terminal His-tagged variant, a C-terminal StrepII-tagged variant, and an 209 
untagged variant. Purity and yield issues with untagged proteins were behind the rational of using 210 
tagged-variants. His-tagged variants were produced for mass-spectrometry analysis, whereas C-211 
terminal StrepII-tagged variants were used in the enzymatic assay where the presence of the His-212 
tag could have interfered with metal binding and catalysis. Native untagged proteins were used for 213 
protein crystallography as, after several attempts, only these variants produced crystals suitable for 214 
X-ray diffraction. Average neutral masses were obtained for each homologue by liquid 215 
chromatography mass spectrometry (Table S5). These all agree with the predicted masses of each 216 
protein and revealed that some of the variants lacked full processing of the initiating methionine. 217 
To interrogate the behaviour of the EncFtn homologues in solution, both the His-tagged and StrepII-218 
tagged variants were subjected to S200 size-exclusion chromatography, calibrated with standards 219 
of known molecular weight, and followed by SDS-PAGE analysis (Fig. 1, Table S6, and Fig. S4). 220 
Hoch_His eluted as three peaks of increasing area: a small peak at ~70 ml consistent with a decamer                                 221 
oligomer; a peak at 81.6 ml consistent with a tetramer; and one at 87.6 ml corresponding to the 222 
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dimer fraction. Pfc_His eluted as a single peak at 64 ml, which has a slightly larger apparent size 223 
than the decamer fraction of Rru_EncFtn (Fig. 1A). When subjected to SDS-PAGE the Hoch_His 224 
peak fractions were partially resistant to SDS and heat-induced denaturation, presenting bands at 225 
the approximate molecular weight of a monomer and dimer species (Fig. S4A); the Pfc_His peak 226 
fractions were almost fully resistant to SDS and heat denaturation with the majority of protein 227 
appearing as a band with an apparent molecular weight greater than that of a decamer, with a small 228 
proportion of monomer (Fig. S4B). Bands corresponding to dimer and monomer states were 229 
observed with Rru_His variant (Fig. S4C). The StrepII-tagged variants of the proteins behaved 230 
slightly differently in solution (Fig. 1B); Hoch_StrepII eluted as a monomer; while the Pfc_StrepII had 231 
a major decamer peak with two additional peaks consistent with higher-order aggregation, such as 232 
dimers of decamers and trimers of decamers. The Rru_StrepII protein eluted primarily as a decamer. 233 
Their appearance on SDS-PAGE gels was almost identical to the His-variants, with the appearance 234 
of some tetramer in the Pfc_StrepII fractions (Fig. S4D/E/F).  235 
Native Mass spectrometry analysis  236 
In order to further understand the differences seen in the solution-phase oligomerization states of 237 
the EncFtn homologues, native mass spectrometry was performed on the His-tagged variant of each 238 
homologue. As previously reported [1], the decameric assembly of iron-bound Rru_EncFtn  can be 239 
successfully detected using this technique. Under native MS conditions (at pH 8.0), Rru_EncFtn 240 
displays a narrow charge state distribution consistent with the 22+ to 25+ charge state of the protein 241 
decamer (Fig. 2A, pink circles). In addition to the decamer, a minor species is observed which is 242 
consistent with the iron-free Rru_EncFtn monomer (+6 and +7) (Fig. 2A, blue circles).  243 
In a similar manner to Rru_EncFtn, native MS analysis of Pfc_EncFtn demonstrates charge state 244 
distributions consistent with a decameric assembly (+23 to +26) (Fig. 2B, pink circles). Interestingly, 245 
the decameric charge state distribution is elongated (Fig. 2B, *) and low abundance (27+ to 31+) 246 
charge states are also observed.  The elongated charge state distribution is only observed in 247 
Pfc_EncFtn, and we attribute its presence to the ability of the solvent-exposed affinity tag to readily 248 
protonate in solution. Similar to the observations from Rru_EncFtn, a charge state distribution 249 
consistent with iron-free Pfc_EncFtn monomer (+5 to +17) is also observed (Fig. 2B, blue circles). 250 
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In contrast, native MS analysis of Hoch_EncFtn does not reveal a major decamer species. Instead 251 
a series of oligomerization states are observed: the major species is a dimer (+9 to +12) (Fig. 2C, 252 
green circles); in addition tetramer (+13 to +16), hexamer (17+ and 18+) and decamer (23+ to 25+), 253 
and a small amount of monomer (+7 to +12) gas phase oligomerization states are all clearly 254 
observed (Fig. 2C, purple circles, orange circles, pink circles, and blue circles respectively). This 255 
observation is consistent with the multiple broad peaks obtained during size-exclusion 256 
chromatography (Fig. 1).  257 
These data suggest that, under our experimental conditions, multiple oligomeric assemblies of Hoch 258 
protein exist in both the solution and gas phase. The observation of even-numbered oligomerization 259 
states (i.e. dimer, tetramer and hexamer) suggests that one of the two dimer interfaces is partially 260 
unstable, and the protein exists as an equilibrium of dimers and higher order multiples of dimers.  261 
Crystal structures of Hoch and Pfc Encapsulated ferritins 262 
To explore the structure of the EncFtn homologues, crystals of native Hoch_EncFtn and Pfc_EncFtn 263 
were produced by standard crystallization screening methods. Diffraction data were collected at 264 
Diamond Light Source and the crystal structures of the Hoch_EncFtn and Pfc_EncFtn proteins were 265 
determined by molecular replacement using a decamer of the Rru_EncFtn (PDB ID: 5DA5) as the 266 
search model [1]. Data collection and refinement statistics are shown in Table 1.  267 
The structure of Hoch_EncFtn was refined at 2.06 Å resolution and contained a decamer in the 268 
asymmetric unit with visible electron density for residues 6 – 96 in each chain (Fig. 3A). Pfc_EnFtn 269 
was refined at 2.03 Å resolution and contained three decamers in the asymmetric unit, with visible 270 
electron density for residues 2-98 in each chain (Fig. 3B). The overall architecture of both structures 271 
mirrors the annular decamer seen in the structure of Rru_EncFtn (Fig. 3C). The electrostatic surfaces 272 
of these proteins display similar features to Rru_EncFtn, with negatively charged patches around 273 
the circumference that correspond to the exterior metal binding sites seen on Rru_EncFtn, and a 274 
negatively charged tunnel at the centre of the decamer corresponding to the interior metal binding 275 
site (Fig. S5). 276 
The monomers of Hoch_EncFtn and Pfc_EncFtn superimpose with an RMSD of 1.21 Å over 74 Ca 277 
atoms. Hoch_EncFtn superimposes on Rru_EncFtn with an RMSD of 0.47 Å over 91 Ca atoms, 278 
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while Pfc_EncFtn superimposes with an RMSD of 1 Å over 71 Ca atoms. While the Hoch_EncFtn 279 
and Rru_EncFtn structures are almost identical, the Pfc_EncFtn structure presents several key 280 
differences to these two proteins. At the N-terminus of Pfc_EncFtn, there is visible electron density 281 
from Gly2, whereas the chains of both Hoch_EncFtn and Rru_EncFtn are not visible until residue 282 
Gln6 and Ser7 respectively. The additional structured residues in Pfc_EncFtn form an extended loop 283 
(Fig. 4), which lies in the central channel of the physiologically active decamer and forms a rigid 284 
constriction when compared to the Hoch_EncFtn and Rru_EncFtn structures (Fig. 3B). The C-285 
terminal a3 helix of Pfc_EncFtn has two additional turns when compared to the other structures and 286 
is shifted by 25° relative to a2 (Fig. 4B/C); this extends its interaction with the neighbouring dimer. 287 
(Fig. 3B).  288 
The main interaction surfaces that make up the decameric arrangement in the proteins correspond 289 
to the ferroxidase centre dimer (FOC) and the non-ferroxidase dimer (non-FOC) interfaces (Fig. 290 
3B/C). Analysis of the extent of these surfaces with PISA [25] gives a buried surface of 1186 Å2 for 291 
the Hoch_EncFtn FOC interface, with 8 hydrogen bonds and 16 salt bridges; and 1712 Å2 in 292 
Pfc_EncFtn, with 14 hydrogen bonds and 6 salt bridges (Fig S6). While Hoch_EncFtn buries roughly 293 
the same surface area in its FOC interface as Rru_EncFtn FOC (1267 Å2), the latter has only 2 294 
hydrogen bonds and 6 salt bridges; the additional stabilization of this interface in Hoch_EncFtn is 295 
likely related to the environmental niche of Haliangium ochraceum, as proteins from halophilic 296 
organisms tend to have an increased number of salt bridges when compared to those from 297 
mesophiles [26]. The Pfc_EncFtn FOC interface has fourteen hydrogen bonds and six salt bridges; 298 
this significant increase in hydrogen bonding over the Rru_EncFtn protein is likely to be a 299 
consequence of the hyperthermophilic nature of Pyrococcus furiosus. The non-FOC interface for 300 
Hoch_EncFtn buries 2338 Å2, which is similar to the 2468 Å2 buried in this region in Rru_EncFtn; 301 
however, there are 18 hydrogen bonds compared to 16 in Rru_EncFtn, and 5 salt bridges compared 302 
to 16 in Rru_EncFtn. These differences are due to a higher proportion of buried hydrophobic residues 303 
in the Hoch_EncFtn interface. The non-FOC interface in the Pfc_EncFtn is less extensive than either 304 
of the other two structures at 1793 Å2, with 19 hydrogen bonds and 19 salt bridges. The extended 305 
structured loop at the N-terminus and shifted a3 helix form one hydrogen bond each to the monomer 306 
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next to their partner in the FOC interface, to bury an additional 586 Å2 of surface area (Fig S6). Taken 307 
together, these two interfaces bury about the same surface area as the non-FOC interfaces of both 308 
Rru_EncFtn and Hoch_EncFtn. The extended interaction surfaces in the Pfc_EncFtn potentially act 309 
as a girdle around the decamer, further stabilizing it at high temperatures. 310 
The residues in the iron binding site of the FOC interface are conserved in the Hoch_EncFtn and 311 
Pfc_EncFtn structures (Fig. 5). The Pfc_EncFtn structure shows clear anomalous difference density 312 
in data collected close to the iron edge at 1.74 Å (Fig. S7; therefore, a dinuclear iron centre was 313 
modelled into the FOC of this structure (Fig. 5). The metal coordination in Pfc_EncFtn is identical to 314 
that seen in Rru_EncFtn, with glutamic acid carboxyl oxygen to iron coordination distances of 2.1 Å, 315 
and histidine nitrogen to iron distances of 2.2 Å. The electron density in the FOC interface of the 316 
Hoch_EncFtn crystal does not contain any peaks or coordinated metal ions (Fig. S7). Given the 317 
importance of the histidine residue (His64) for iron coordination [1] and the fact that the protein 318 
crystallized in a buffer at pH 5.5, this histidine residue is likely to be around 70 % protonated and 319 
would be unable to coordinate iron in this state, thus explaining the absence of iron in this site. In 320 
the absence of iron in the Hoch_EncFtn structure, the side-chain of Glu31 is flipped 180° and is 321 
within hydrogen bonding distance of Tyr38 from the partner chain, presumably stabilizing the apo-322 
form of this interface (Fig. 5A).  323 
The secondary metal coordination sites seen in the structure of Rru_EncFtn are fully conserved in 324 
Hoch_EncFtn and only partially so in Pfc_EncFtn. The metal binding site at the centre of the 325 
decameric ring comprises Glu30/Glu33 in Hoch_EncFtn and Ala31/Asp34 in Pfc_EncFtn. Neither 326 
structure has any coordinated metal ions in this site (Fig. 5B).  327 
The side-chains of the glutamic acid residues (Glu31/Glu34 in Rru_EncFtn numbering) are shifted 328 
when compared to those in Rru_EncFtn; this could be linked to the absence of a metal ion. The 329 
external metal binding site of Hoch_EncFtn is identical to the Rru_EncFtn site, while the Pfc_EncFtn 330 
has a glutamic acid in place of a histidine and alanine in place of a glutamic acid in this site. 331 
Given the observation that a decameric form of Hoch_EncFtn was obtained in crystals at pH 5.5, the 332 
influence of pH on protein oligomerization was investigated using native MS. Experiments were 333 
performed in pH 5.5 ammonium acetate, and under these acidic conditions MS analysis reveals a 334 
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substantial increase in the abundance of the decameric species (21+ to 25+) (Fig. S8), similar to the 335 
level seen for Pfc_EncFtn and Rru_EncFtn. The lower order oligomerization states, present at pH 336 
8.0, are significantly reduced in abundance and only dimer (9+ and 10+) and tetramer (14+ and 15+) 337 
minor species are observed (Fig. S8, green and purple circles respectively). Taken together, our 338 
native MS observations suggest that a stable Hoch EncFtn dimer is readily formed irrespective of 339 
pH; and under acidic conditions, Hoch_EncFtn dimers favour assembly into the higher order 340 
pentamer-of-dimers annular structure which is characteristic of this class of protein. 341 
Ferroxidase activity 342 
Given the absolute conservation of the FOC residues in Hoch_EncFtn, Pfc_EncFtn and Rru_EncFtn, 343 
the ferroxidase activity of the EncFtn homologues was tested to determine if they were indeed active 344 
as ferroxidase enzymes. Encapsulated ferritin StrepII-tagged variants were assayed for their 345 
ferroxidase activity by following progress curves for iron oxidation at 315 nm at 20 °C. Each of the 346 
proteins displayed similar activity profiles, with some small differences in the shape of the progress 347 
curves. Hoch_EncFtn exhibits a higher initial rate than the other homologues (Fig. 6). Overall these 348 
data confirm the ferroxidase activity of the EncFtn family across different species from distinct 349 
environmental niches.  350 
The metal content of the purified protein fractions used for enzymatic assays was determined by 351 
inductively coupled plasma mass spectrometry (Table S7). Iron levels determined in StrepII-tagged 352 
monomeric Hoch_EncFtn variants and StrepII-tagged decameric Pfc_EncFtn and Rru_EncFtn 353 
variants show an iron to protein ratio consistent with 40-80 % occupancy of the ferroxidase centre, 354 
assuming all of the iron is located within this site. A ~50 % occupancy of the ferroxidase centre was 355 
also observed with the His-tagged EncFtn variants which were used in the mass-spectrometry 356 
analysis. 357 
Significant amounts of zinc were copurified with all protein samples in this study, with varying levels 358 
detected in the forms with different tags. Zinc is known to strongly inhibit the ferroxidase activity of 359 
ferritin family proteins via competitive binding to the ferroxidase centre [27]. Given the structural 360 
differences between encapsulated ferritins and the classical ferritins, and the differences in 361 
secondary metal-binding sites displayed by Pfc_EncFtn, the inhibitory effect of zinc on the EncFtn 362 
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homologues was tested by performing the ferroxidase assays in the presence of increasing 363 
concentrations of zinc. The results show that increasing zinc concentrations lead to a decrease in 364 
the slope and final level of ferroxidase progress curves for all of the EncFtn variants, with a maximum 365 
inhibition seen with ~ 40-100 µM Zn (Fig. S9). These data were fitted using a nonlinear regression 366 
with a dose-response model with three parameters, where the response (zero-subtracted end-point 367 
absorbance at 315 nm) was the average of three replicates per condition (Fig. 7). The calculated 368 
IC50 values for zinc inhibition of the three EncFtn variants (Table S8) show significant differences, 369 
with the Rru_EncFtn showing the lowest, and Hoch_EncFtn the highest IC50 values. The lower 370 
susceptibility of the Hoch_EncFtn to zinc dependent inhibition could be a consequence of a higher 371 
level of ferroxidase activity, or structural differences that influence metal binding and discrimination. 372 
 373 
 374 
 375 
  376 
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Discussion 377 
The recently published structural and functional analysis of the R. rubrum encapsulated ferritin 378 
system presented a new functional organization for iron mineralization by ferritin-like proteins, with 379 
the four-helix bundle ferritin-like fold formed through the interaction of EncFtn subunits to form a 380 
functional ferroxidase centre [1]. The open decameric structure of the EncFtn protein is not 381 
competent to store iron in mineral form; instead, the interaction with, and sequestration within, the 382 
encapsulin nanocage provides a functional and high-capacity iron storage system [3,4]. To 383 
understand whether the structural organization of the EncFtn family is conserved across 384 
microorganisms with different environmental niches and distinct encapsulin geometries, we 385 
determined the structure and biochemical properties of EncFtn proteins from H. ochraceum and P. 386 
furiosus.  387 
P. furiosus is a hyperthermophilic Euryarchaeota and its encapsulin was the first to be characterized; 388 
however, it was initially mis-annotated as a non-functional virus-like particle [13]. The P. furiosus 389 
encapsulin forms a contiguous polypeptide chain with an N-terminal EncFtn domain appended to it 390 
and assembles into a 180 subunit T=3 capsid. This archaeal arrangement is distinct to the bacterial 391 
EncFtn/encapsulin systems, which are usually encoded in a two-gene operon with the EncFtn 392 
upstream of the encapsulin, and with a short C-terminal encapsulation sequence peptide appended 393 
to the encoded EncFtn protein [5,10]. It is not clear whether the genomic arrangement of the bacterial 394 
EncFtn/encapsulin systems arose separately, or by horizontal gene transfer from archaea followed 395 
by mutation of the single-reading frame into two, along with the mutation of the T=3 form of the 396 
encapsulin to the T=1 form found in the bacterial EncFtn encapsulins. 397 
 The published crystal structure of the P. furiosus encapsulin lacks any electron density for 398 
the EncFtn domain, implying that this domain is mobile within the encapsulin nanocage even though 399 
it is contiguous with and tethered to the encapsulin protein [13]. Our analysis focused on the isolated 400 
P. furiosus EncFtn domain, which forms a decamer in solution, the gas phase, and in crystals. This 401 
domain is partially resistant to thermal and SDS induced denaturation, which is in accord with the 402 
extreme temperatures endured by the host organism in its volcanic niche. 403 
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The current model for the organization of bacterial EncFtn proteins within encapsulin nanocages 404 
places the decamers at the pentameric vertices of the T=1 capsid [1,4] with the encapsulation 405 
sequences of five subunits captured by clefts on the interior surface of the penton of the encapsulin 406 
shell. The encapsulation sequences of the other five subunits in the decamer are disengaged and 407 
free within the interior of the capsid. No evidence is available on the strength of the interaction 408 
between the capsid and the EncFtn protein; however, the presence of clear electron density for some 409 
of the encapsulation sequence in the T. maritima encapsulin structure implies that the interaction is 410 
relatively stable, and this is enhanced by an avidity mechanism with multiple encapsulation 411 
sequences engaged by subunits at the pentameric vertex [4]. In the archaeal systems the EncFtn 412 
and encapsulin domains are a contiguous polypeptide, with the EncFtn domain tethered to the 413 
interior of the capsid. The T=3 geometry of the P. furiosus encapsulin has 180 subunits, with 12 414 
penton units and 20 hexons. Given the structural and biochemical conservation of the decameric 415 
EncFtn protein, it is likely that this arrangement is found within the T=3 as well as T=1 capsids. It is 416 
not clear how the decamer could be formed from tethered subunits unless the EncFtn domains found 417 
in hexons have enough flexibility in the linker between domains to engage with partners in adjacent 418 
pentons. With full engagement at the pentons, this would leave 60 ‘free’ EncFtn domains within the 419 
capsid. This observation, coupled with our solution and gas phase experiments, indicates that the 420 
quaternary structure of EncFtn proteins is dynamic and that they can exist in equilibrium between 421 
monomers/dimers and higher order multiples of dimers. 422 
 The dynamic nature of EncFtn proteins is highlighted in our solution and gas phase analyses 423 
of the H. ochraceum EncFtn. Despite high sequence identity and the conservation of key residues 424 
between it and the R. rubrum EncFtn, this protein is less prone to multimerization in solution and 425 
displays a greater range of oligomerization intermediates than both the R. rubrum and P. furiosus 426 
EncFtn proteins in the gas phase. The presence of the conserved EncFtn decamer quaternary 427 
structure in the crystal highlights the conservation of this architecture. The absence of metal ions in 428 
the crystal structure, which was formed at pH 5.5, indicated that the quaternary structure can be 429 
induced by both metal binding, as was shown in solution for the R. rubrum EncFtn [1], and changes 430 
in pH, presumably through the protonation of the conserved histidine at low pH and the formation of 431 
stabilizing hydrogen bonds by residues normally involved in the formation of the FOC.  432 
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Analysis of the structure and sequence of the H. ochraceum EncFtn indicates that the dimerization 433 
interfaces are less extensive than the R. rubrum EncFtn interfaces and are discontinuous. This leads 434 
to lower binding energies for both of the interfaces when compared to both R. rubrum and P. furiosus, 435 
and this could explain the differences in stability seen in solution and the gas phase.  436 
We show here that the three proteins in this study exhibit comparable ferroxidase activities. This 437 
indicates that they were purified in a functional state. Previous reports show that ferritins are 438 
susceptible to inhibition by Zn(II) ions [27], which is also the case for the EncFtn family as 439 
demonstrated in this study. In the experimental conditions used in our study, the H. ochraceum 440 
EncFtn was slightly more active than the other proteins and less susceptible to inhibition by zinc. 441 
This may be a consequence of the more dynamic nature of this homologue, as seen in solution and 442 
the gas phase. The precise mode of catalysis for ferritins is a subject of some debate and key 443 
questions as to whether the iron ions engaged within the ferroxidase centre are labile, or act as a 444 
stable prosthetic centre; and whether the two iron ions move in concert are the subject of some 445 
controversies in the field [28,29]. Our study does not aim to address these controversies, but we do 446 
note that the location of the conserved FOC and secondary metal binding sites at a dimer interface 447 
and the dynamic nature of EncFtn oligomerization may indicate a distinct mechanism of iron 448 
oxidation and transfer to minerals when compared to the classical ferritins, thus adding a new level 449 
of complexity and debate to the field. It must also be noted that the activity of EncFtn proteins occurs 450 
within the privileged environment of an encapsulin shell, which adds an additional level of complexity 451 
to the study of their catalysis.  452 
Analysis of the sequence alignment (Fig. S3) highlights the absence of conserved residues found in 453 
the putative metal ion entry site found in the other EncFtn homologues. Our observation that Pfc 454 
EncFtn displays ferroxidase activity highlights that conservation of this site is not a prerequisite for 455 
catalysis. However, it is clear that Pfc_EncFtn has the lowest enzymatic activity of the three 456 
homologues, it may be that that the acidic residues found in this location attract iron ions and channel 457 
them to the FOC. Their absence in Pfc_EncFtn implies that metal ions reach its FOC simply by 458 
diffusion, resulting in a slower Fe(II)/Fe(III) turn-over and hence a reduction in enzyme activity. It 459 
would be interesting to apply a mutagenesis approach to further explore the role of these proposed 460 
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entry site residues on the ferroxidase activity. The modest catalytic activity displayed by Pfc_EncFtn 461 
could also be interpreted by considering that P. furiosus achieves optimal growth at ~ 100 °C, 462 
whereas enzymatic experiments were conducted at room temperature to allow the comparison of 463 
activities.  464 
Further study will shed light on the role of the different dimerization interfaces on the stability of the 465 
EncFtn decamer; and the role of the secondary metal binding sites on catalysis, metal selectivity, 466 
and catalytic inhibition by competing metal ions. 467 
  468 
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Tables 578 
Table 1. X-ray diffraction data collection and refinement statistics. 579 
 Hoch_EncFtn Pfc_EncFtn* 
Data collection   
Wavelength (Å) 1.72 1.74 
Resolution range (Å) 47.82 - 2.06 
(2.13 - 2.06) 
47.19 - 2.03 
(2.1 - 2.03) 
Space group C 1 2 1 P 1 21 1 
Unit cell (Å) 
              b (°) 
91.63, 92.65, 119.29 
106.94 
99.85, 110.06, 136.27 
91.22 
Total reflections 30,0549 (27,242) 1,226,338 (112,156) 
Unique reflections 57,293 (5,570) 374,905 (36,076) 
Multiplicity 5.2 (4.9) 3.3 (3.0) 
Completeness (%) 96.3 (94.1) 97.0 (95.4) 
Mean I/sigma(I) 10.16 (2.37) 10.48 (4.02) 
Wilson B-factor (Å2) 31.7 22.8 
Rmerge (%) 9.4 (59.6) 8.0 (36.3) 
Rmeas (%) 10.5 (66.7) 9.5 (44.1) 
Rpim (%) 4.4 (29.2) 5.2 (24.7) 
CC1/2 (%) 100 (99.9) 99.5 (90.2) 
CC* (%) 100 (97.6) 100 (97.4) 
Image DOI 10.5281/zenodo.322743 10.5281/zenodo.344797 
Refinement   
Reflections used in refinement 57,082 (5,563) 365,581 (36,036) 
Reflections used for R-free 2,765 (284) 17,934 (1697) 
Rwork (%)  20.1 (29.5) 17.5 (22.3) 
Rfree (%) 24.5 (34.5) 20.2 (24.5) 
CC(work) (%)  96.4 (92.6) 96.7 (92.3) 
CC(free) (%) 93.6 (85.1) 95.3 (90.3) 
Non-hydrogen atoms 7,819 25,735 
  macromolecules 7,650 23,691 
  ligands 1 30 
  Water 168 2,014 
Protein residues 916 2,922 
RMS(bonds) (Å) 0.003 0.002 
RMS(angles) (°) 0.46 0.44 
Ramachandran   
  favoured (%) 98.7 99.9 
  allowed (%) 1.3 0.10 
  outliers (%) 0.00 0.00 
Rotamer outliers (%) 0.96 0.39 
Clashscore 1.20 1.15 
Average B-factor (Å2) 44.6 29.0 
  macromolecules 44.6 28.3 
  ligands 34.7 19.7 
  solvent 43.7 36.7 
PDB ID 5N5F 5N5E 
*Anomalous pairs were counted separately for Pfc_EncFtn, as this model was refined against the split 580 
anomalous data. Statistics for the highest-resolution shell are shown in parentheses. 581 
 582 
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Figures 583 
 584 
Figure 1. Purification of recombinant R. rubrum, H. ochraceum, and P. furiosus EncFtn 585 
proteins. A, Recombinant His-tagged Hoch_His, Pfc_His, and Rru_His proteins were purified by 586 
nickel NTA-affinity chromatography and subjected to analytical size-exclusion chromatography 587 
using a Superdex 200 16/60 column (GE Healthcare) equilibrated with 50 mM Tris-HCl, pH 8.0, 588 
150 mM NaCl. The peaks near 70 ml correspond to an estimated molecular weight of >130 kDa 589 
when compared to calibration standards, consistent with oligomerisation states equal or greater 590 
than decameric. The Hoch_His at around 80 ml corresponds to the 50 kDa tetramer and the peaks 591 
near 88 ml correspond to the 31 kDa dimer compared to the standards. B, Recombinant Strep-592 
tagged Hoch_StrepII, Pfc_StrepII, and Rru_StrepII proteins were purified by Strep-Trap column HP 593 
(GE Healthcare). Purified samples were applied to a Superdex 200 16/60 column (GE Healthcare) 594 
equilibrated with 50 mM Tris-HCl, pH 8.0, 150 mM NaCl in order to observe oligomerization state 595 
in solution. Rru_StrepII elutes primarily at ~ 70 ml, corresponding to the decamer size. Pfc_StrepII 596 
peaks can be found around 60 ml (~ 24-mer) and at 70 ml (12-mer), whereas Hoch_StrepII elutes 597 
at ~ 83 ml (4-mer). Elution volumes and corresponding oligomerisation states are summarised in 598 
Table S6. DOI: 10.6084/m9.figshare.7105907 599 
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 601 
Figure 2. Native mass spectrometry of encapsulated ferritin homologues. Native 602 
nanoelectrospray ionization (nESI) mass spectrometry of encapsulated ferritin homologues 603 
acquired in 100 mM ammonium acetate (pH 8.0). A: nESI spectrum of Rru_EncFtn consistent with 604 
decameric assembly. The decameric charge state distribution is represented with pink circles and 605 
peaks correspond to 22+ to 25+ charge states. Two minor monomer charge states (blue circles, 6+ 606 
and 7+ charge states) are also observed. B: Native spectrum of Pfc_EncFtn. Decamer charge 607 
states (23+ to 31+) are highlighted with pink circles and monomer charge states (5+ to 17+) are 608 
highlighted by blue circles. * denotes the extended charge state observed. C: nESI spectrum of 609 
Hoch_EncFtn with gas phase oligomerization stressed with coloured circles. Monomer shown as 610 
blue; dimer as green; tetramer as purple; hexamer as yellow and decamer as pink.  611 
  612 
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 613 
Figure 3. Encapsulated ferritins from Haliangium ochraceum and Pyrococcus furiosus form 614 
annular decamers. The annular decameric architecture of the encapsulated ferritins from 615 
Haliangium ochraceum, A, and Pyrococcus furiosus, B, are shown as transparent solvent 616 
accessible surfaces over secondary structure cartoons. The published structure of the 617 
Rhodospirillum rubrum encapsulated ferritin is shown for comparison, C (PDB ID: 5DA5) [1]. 618 
Bound metal ions are shown as spheres: iron ions are depicted in orange, and calcium ions in 619 
grey. The positions of the N- and C-termini of the protein chains and five-fold symmetry axis are 620 
highlighted in panel A. 621 
  622 
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 623 
Figure 4. Crystal structures of encapsulated ferritins from Haliangium ochraceum and 624 
Pyrococcus furiosus. Secondary structure cartoon depictions of the structures of the protomers 625 
and dimers found in the crystal structures of the Hoch_EncFtn and Pfc_EncFtn encapsulated 626 
ferritins. A, orthogonal views of the protomers: Hoch_EncFtn shown in orange; Pfc_EncFtn in 627 
purple; and Rru_EncFtn in green for comparison (PDB ID: 5DA5) [1]. B, orthogonal views of the 628 
ferroxidase centre dimer. Iron ions present in the Pfc_EncFtn dimer are shown as orange spheres. 629 
No metal ions were present in the Hoch_EncFtn structure. Hoch_EncFtn is shown in 630 
orange/yellow; Pfc_EncFtn in purple/pink; and Rru_EncFtn in green/blue. C, orthogonal views of 631 
the non-FOC dimer, depicted as in B. 632 
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 634 
Figure 5. Ferroxidase centre and putative metal binding sites of encapsulated ferritins. 635 
Orthogonal views of the ferroxidase centre (A) and putative secondary metal binding sites (B/C) of 636 
Hoch_EncFtn (yellow/orange) and Pfc_EncFtn (pink/purple) compared to Rru_EncFtn (PDB ID: 637 
5DA5) [1] (blue/green). A, conserved ferroxidase centre residues are numbered for Hoch_EncFtn 638 
and Pfc_EncFtn. Iron ions found in the Pfc_EncFtn FOC are shown as gold spheres with 639 
coordination distances to side chain atoms shown. The positions of the iron ions in the Rru_EncFtn 640 
structure are shown as orange spheres. B, residue conservation in the site occupied by calcium in 641 
the Rru_EncFtn structure (grey sphere, with coordination distances). C, conserved residues on the 642 
outer surface of the encapsulated ferritin surface, located 10 Å from the FOC.  643 
  31 
 644 
Figure 6. Ferroxidase activity of encapsulated ferritins. Hoch_StrepII(dotdash orange line), 645 
Pfc_StrepII(dashed pink line), and Rru_StrepII(solid green line) (10 μM monomer) were incubated 646 
with 50 μM FeSO4.7H2O (10 times molar equivalent Fe2+ per FOC) and progress curves of the 647 
oxidation of Fe2+ to Fe3+ was monitored at 315 nm at room temperature. The background oxidation 648 
of iron at 50 μM in enzyme-free control is shown for reference (dotted grey line). Solid lines 649 
represent the average (n = 3) of technical replicates, shaded areas represent standard deviation 650 
from the mean. Protein and iron samples were prepared anaerobically in Buffer H (10 mM HEPES 651 
pH 8.0, 150 mM NaCl), and 0.1 % (v/v) HCl, respectively. DOI: 10.6084/m9.figshare.7718879 652 
  653 
  32 
 654 
Figure 7. The ferroxidase activity of encapsulated ferritins is inhibited by zinc. A, B, C, Non-655 
linear fit of ferroxidase activities of Strep-tagged proteins inhibited by varying concentrations of 656 
Zn(II) by GraphPad software using a Dose-Response (log(inhibitor) vs. response (three 657 
parameters) equation. Response used in this analysis is the average of three technical replicates 658 
per condition. Data shown were recorded after 1500 seconds from the start of the assay. IC50 and 659 
logIC50 have been calculated for each protein (Table S8). Protein and metal samples were 660 
prepared anaerobically in Buffer H (10 mM HEPES pH 8.0, 150 mM NaCl), and 0.1 % (v/v) HCl, 661 
respectively. DOI: 10.6084/m9.figshare.7718879 662 
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Table S1.  Primers used in this study 31 
Construct Forward Primer Reverse Primer Comment 
Rru_EncFtn GGCCCATGGCGCAGTCGAGCAATAGCACC AAGGAATTCGCCGCGGTGATCGGCCCCTC NcoI, BamHI 
Hoch_EncFtn GGCTTGGTCTCAAATGGGCAGCAGCGAACAGCTG GCGTAGGTCTCTAAGCTTATTCTTCCAGTTCCAGAA
TCGGACGTTC 
BsaI sites 
Pfc_EncFtn GATCCATGGGCCTGAGCATCAACCCCACCCT GGCGGATCCTTAGGCCTCGATGCCGGTCAG NcoI, BamHI 
All primers were purchased from IDT. Underlined regions represent restriction enzyme recognition sites; highlighted regions represent type IIs restriction enzyme 32 
cut sites; and bold underlined regions represent type II restriction enzyme recognition and cutting sequences.   33 
Table S2. gBlocks used in this study 34 
Construct Sequence Comment 
Rru_EncFtn GGCGGTCTCTAATGGCACAGAGCAGCAATAGCACCCATGAACCGCTGGAAGTTCTGAAAGAAGAAACCGTTAATCGTCATCGTGC
AATTGTTAGCGTTATGGAAGAACTGGAAGCAGTGGATTGGTATGATCAGCGTGTTGATGCAAGCACCGATCCGGAACTGACCGCA
ATTCTGGCACATAATCGTGATGAAGAAAAAGAACATGCAGCAATGACCCTGGAATGGCTGCGTCGTAATGATGCAAAATGGGCAG
AACATCTGCGTACCTACCTGTTTACCGAAGGTCCGATTACCGCAATTAGGTAGAGACCGAC 
BsaI sites, 
CIDAR MoClo 
A/C overhangs 
Hoch_EncFtn GACGGTCTCTAATGAGCAGCGAACAGCTGCATGAACCGGCAGAACTGCTGAGCGAAGAAACCAAAAACATGCATCGTGCACTGGT
TACCCTGATTGAAGAACTGGAAGCAGTTGATTGGTATCAGCAGCGTGCAGATGCCTGTAGCGAACCGGGTCTGCATGATGTTCTG
ATTCATAACAAAAACGAAGAGGTGGAACATGCAATGATGACCCTGGAATGGATTCGTCGTCGTAGTCCGGTTTTTGATGCACACA
TGCGTACCTACCTGTTTACCGAACGTCCGATTCTGGAACTGGAAGAAAGGTAGAGACCGAC 
BsaI sites, 
CIDAR MoClo 
A/C overhangs 
Pfc_EncFtn GGCGGTCTCTAATGCTGAGCATTAATCCGACGCTGATTAATCGTGATAAACCGTATACCAAAGAAGAACTGATGGAAATTCTGCG
CCTGGCAATTATTGCAGAACTGGATGCAATTAATCTGTACGAGCAGATGGCACGTTATAGCGAAGATGAAAATGTGCGTAAAATT
CTGCTGGATGTTGCCCGTGAAGAAAAAGCACATGTTGGTGAATTTATGGCACTGCTGCTGAATCTGGATCCGGAACAGGTTACCG
AACTGAAAGGTGGTTTTGAAGAAGTTAAAGAACTGACCGGCATCGAAAGGTAGAGACCGAC 
BsaI sites, 
CIDAR MoClo 
A/C overhangs 
Double stranded DNA gBlocks were purchased from IDT. Underlined regions represent restriction enzyme recognition sites; highlighted regions represent type 35 
IIs restriction enzyme cut sites.36 
  
Table S3. Constructs used in this study 37 
Construct Sequence Amino acids 
Average 
Molecular weight 
(Da) 
pI Extinction coefficient (M
-1 
cm-1) 
Rru_EncFtn 
MAQSSNSTHEPLEVLKEETVNRHRAIVSVMEELEAVDWYD
QRVDASTDPELTAILAHNRDEEKEHAAMTLEWLRRNDAKW
AEHLRTYLFTEGPITAANS 
99 11417.60 4.80 19480 
Rru_His 
MAQSSNSTHEPLEVLKEETVNRHRAIVSVMEELEAVDWYD
QRVDASTDPELTAILAHNRDEEKEHAAMTLEWLRRNDAKW
AEHLRTYLFTEGPITAANSSSVDKLAAALEHHHHHH 
116 13325.67 5.34 19480 
Rru_StrepII 
MAQSSNSTHEPLEVLKEETVNRHRAIVSVMEELEAVDWYD
QRVDASTDPELTAILAHNRDEEKEHAAMTLEWLRRNDAKW
AEHLRTYLFTEGPITAIRSWSHPQFEK 
107 12541.91 5.04 24980 
Hoch_EncFtn 
MGSSEQLHEPAELLSEETKNMHRALVTLIEELEAVDWYQQ
RADACSEPGLHDVLIHNKNEEVEHAMMTLEWIRRRSPVFD
AHMRTYLFTERPILELEE 
98 11572.03 4.76 13980 
Hoch_His 
MGSSEQLHEPAELLSEETKNMHRALVTLIEELEAVDWYQQ
RADACSEPGLHDVLIHNKNEEVEHAMMTLEWIRRRSPVFD
AHMRTYLFTERPILELEHHHHHH 
103 12265.76 5.43 13980 
Hoch_StrepII 
MSSEQLHEPAELLSEETKNMHRALVTLIEELEAVDWYQQR
ADACSEPGLHDVLIHNKNEEVEHAMMTLEWIRRRSPVFDA
HMRTYLFTERPILELEERSWSHPQFEK 
107 12798.39 4.97 19480 
Pfc_EncFtn 
MGLSINPTLINRDKPYTKEELMEILRLAIIAELDAINLYE
QMARYSEDENVRKILLDVAREEKAHVGEFMALLLNLDPEQ
VTELKGGFEEVKELTGIEA 
99 11304.01 4.49 4470 
Pfc_His 
MGLSINPTLINRDKPYTKEELMEILRLAIIAELDAINLYE
QMARYSEDENVRKILLDVAREEKAHVGEFMALLLNLDPEQ
VTELKGGFEEVKELTGIEAQDPNSSSVDKLAAALEHHHHH
H  
121 13753.59 4.88 4470 
Pfc_StrepII 
MLSINPTLINRDKPYTKEELMEILRLAIIAELDAINLYEQ
MARYSEDENVRKILLDVAREEKAHVGEFMALLLNLDPEQV
TELKGGFEEVKELTGIERSWSHPQFEK 
107 12459.29 4.7 9970 
38 
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Table S4. Protein quantification by BCA assay.  
Protein Dilution factor Average DA562 (AU) [protein] mg/ml 
Rru_His / - 0.5  0.30 1.00 
Pfc_His / 0.46 1.50 
Hoch_His / - 0.5 0.47 1.50 
Rru_StrepII 0.5 0.45 7.57 
Pfc_StrepII / - 0.5 - 0.2 0.37 5.23 
Hoch_StrepII / - 0.5 - 0.2 0.16 1.03 
Purified proteins were quantified by BCA assay following manufacturer specifications. In some cases, 
dilution of sample was required to be within the assay sensitivity (0 - 2 mg/ml). Total protein 
concentration is calculated by comparison to the standard bovine serum albumin (BSA). BSA 
standard curves are shown in Fig. S3. DOI 10.6084/m9.figshare.7756544 
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Table S5. Average molecular masses of encapsulated ferritins obtained by LC-MS.  
Protein Observed Mass (Da) Assignment Theoretical Mass (Da) 
Rru_His 
13194.20 ± 0.19 monomer without Met 13194.47 
26387.19 ± 1.37 dimer without Met 26388.94 
Rru_StrepII 
12411.41 ± 0.25 monomer without Met 12410.71 
24822.61 ± 1.00 dimer without Met 24821.42 
Hoch_His 
12663.85 ± 0.06 monomer without Met 12664.12 
12794.22 ± 0.78 monomer with Met 12795.31 
Hoch_StrepII 
12666.19 ± 0.11 monomer without Met 12667.20 
25331.96 ± 0.47 dimer without Met 25334.4 
Pfc_His 13622.35 ± 0.42 monomer without Met 13622.40 
Pfc_StrepII 12460.60 ± 0.60 monomer with Met 12459.29 
The starting Methionine residue is not always retained, and this has been indicated in “Assignment”. 
Error values generated from MassLynx. 
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Table S6. Elution volumes and oligomerisation states of EncFtn protein peaks observed in size 
exclusion chromatography profiles. 
Protein Theoretical 
Mass (Da) 
Peak 1 Peak 2 Peak 3 
Rru_His 
 
13194.47 Ve =  
67.60 
ml 
156 
kDa 
12-mer 
Ve =  
82.9 ml 
45 kDa 
4-mer 
  
Rru_StrepII 12410.71 Ve =  
69.34 
ml 
136 
kDa 
11-mer 
    
Pfc_His 13622.40 Ve =  
63.95 
ml 
211 
kDa 
15-mer 
    
Pfc_StrepII 12459.29 Ve =  
54.63 
448 
kDa 
36-mer 
Ve =  
59.36 
305 
kDa 
24-mer 
Ve =  
68.52 
ml 
145 
kDa 
12-mer 
Hoch_His 12795.31 Ve =  
69.72 
ml 
132 
kDa 
10-mer 
Ve =  
81.59 
ml 
50 kDa 
4-mer 
Ve =  
87.57 
ml 
31 kDa 
2-mer 
Hoch_StrepII 12667.20 Ve =  
77.13 
72 kDa 
6-mer 
Ve =  
82.63 
ml 
46 kDa 
4-mer 
  
Experimental molecular masses were calculated using elution volume (Ve) values observed for each 
peak in size exclusion elution profiles. Column was calibrated by using the GE Healthcare Gel filtration 
calibration kits (LMW/HMW) prepared according to manufacturer instructions. The oligomerisation state 
was obtained by comparison with theoretical mass.
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Table S7. Iron and zinc content of purified EncFtn protein samples from ICP-MS analysis 1 
Protein [Fe]/[protein] %  [Fe]/[Zn] [Fe]/[FOC] 
Rru_His 25.5 5.4 0.5 
Rru_Strep 17.9 ± 4.7 0.6 ± 0.1 0.4 ± 0.1 
Hoch_His 24.8 2.6 0.5 
Hoch_Stre
p 29.1 ± 17.1 
1.2 ± 0.2 0.6 ± 0.3 
Pfc_His 20.5 1.7 0.4 
Pfc_Strep 42.1 ± 16.5 0.9 ± 0.2 0.8 ± 0.3 
Fe and Zn content was analysed by ICP-MS on decameric (Rru and Pfc variants) and monomeric 2 
protein fractions (Hoch variants). Proteins were prepared in Buffer GF (50 mM Tris-HCl pH 8.0, 150 3 
mM NaCl). Where applicable the analysis was performed on n=3 replicates and values shown represent 4 
mean average of values and standard deviation. 5 
DOI: 10.6084/m9.figshare.7105937  6 
 7 
  8 
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Table S8. Calculated logIC50 and IC50 values for Rru_StrepII, Pfc_StrepII, Hoch_StrepII  9 
Protein logIC50 IC50 (µM) 
Rru_StrepII 1.5 34.4 
Hoch_StrepII 1.9 80.2 
Pfc_StrepII 1.6 43.7 
IC50 and logIC50 values were calculated by non-linear fit of ferroxidase activities of Strep-tagged proteins 10 
inhibited by varying concentrations of Zn(II) by GraphPad software using a Dose-Response 11 
(log(inhibitor) vs. response (three parameters) equation. An average of three technical replicates per 12 
condition was used as response. DOI: 10.6084/m9.figshare.771887913 
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 14 
Figure S1. Calibration of gel-filtration column. A, HiLoad 16/60 Superdex gel-filtration column was 15 
calibrated by running LMW/HMW calibration kits (GE Healthcare) to measure the elution volume (Ve) 16 
of each protein standard. Buffer used was 50 mM Tris-HCl, pH 8.0 150 mM NaCl, The void volume 17 
(Vo) of this particular column was estimated to be 43.88 ml based on the retention volume of blue 18 
dextran 2000. The Kav value was derived based on the equation: (Ve – Vo) / (Vc – Vo), where Vc is the 19 
total bed volume of the gel-filtration column (120.64 ml). Figure B shows Kav plotted against LogMr of 20 
protein standards. Apparent Molecular weight can therefore be calculated from protein retention 21 
volume (Ve) using the following equation: Log MW (Da) = (Kav – 2.226) / -0.3691. DOI  22 
10.6084/m9.figshare.7752320 23 
  24 
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 25 
Figure S2. Bovine serum albumin standard curves. BCA colour response curves produced using 26 
the Standard Test Tube Protocol (PierceTM BCA Protein Assay Kit) to quantify His-tagged proteins (A), 27 
and Strep-tagged proteins (B). 28 
  29 
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 30 
 31 
 32 
Figure S3. Protein sequence alignment of encapsulated ferritin proteins highlighting conserved 33 
residues. The protein sequences of Hoch_EncFtn, Pfc_EncFtn, and Rru_EncFtn were aligned using 34 
Clustal Omega [1] and displayed using ESPript [2]. Secondary structure elements from the crystal 35 
structure of Rru_EncFtn (PDB ID:5DA5) [3] are shown above the alignment. Conserved residues are 36 
shown with a red background; while partially conserved residues are shown with red text; extended 37 
regions of sequence conservation are shown with a blue border. Conserved FOC residues are 38 
highlighted with black stars; metal entry-site residues with black ovals; and metal exit-site residues with 39 
open ovals. The conserved C-terminal encapsulin localization sequence is highlighted with a black bar. 40 
  41 
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 42 
Figure S4. SDS-PAGE analysis of EncFtn proteins after size-exclusion chromatography. SDS-43 
PAGE analysis (15 % w/v polyacrylamide) of peak fractions from size-exclusion chromatography 44 
(A/B/C) or Strep-trap (D/E/F) purification steps. Figures A/B/C show band resolution of Rru_His (Vepeak 45 
1 = 67.6 ml, Vepeak 2 = 82.9 ml), Pfc_His (Vepeak 1 = 64 ml), and Hoch_His (Vepeak 1 = 69.7 ml, Vepeak 2 = 46 
81.6 ml, Vepeak 3 = 87.6 ml) respectively. Figures D/E/F show Rru_StrepII, Pfc_StrepII, Hoch_StrepII, 47 
respectively, where protein fractions result from a single peak eluted from Strep-Trap column. 48 
Oligomerization states are reported on the gel images. 49 
  50 
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 51 
Figure S5. Negatively charged patches on the surface of encapsulated ferritins correspond to 52 
metal binding sites. The solvent accessible surfaces of decamers of Hoch_EncFtn, A, Pfc_EncFtn, B, 53 
and Rru_EncFtn, C, are shown, coloured by electrostatic potential as calculated using the APBS plugin 54 
in PyMOL. Negatively charged regions are coloured red and positive regions in blue, neutral regions in 55 
grey. At top, view of the surface looking down the central axis; middle, orthogonal view of top; bottom, 56 
cutaway view showing the central cavity of the decameric ring. 57 
58 
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 59 
Figure S6. Encapsulated ferritin dimer interface residues. Residues in the dimer interfaces of 60 
encapsulated ferritins were determined using the EBI PISA server [4] and displayed using PyMol.  A, 61 
D, ferroxidase and non-ferroxidase interfaces of Hoch_EncFtn; B, E, ferroxidase and non-ferroxidase 62 
interfaces of Pfc_EncFtn; ferroxidase and non-ferroxidase interfaces of Rru_EncFtn. Protein secondary 63 
structures are shown in cartoon representation, with the side-chains of interface residues shown as 64 
sticks; bound iron ions are shown as orange spheres; and polar contacts as yellow dashed lines. 65 
  66 
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67 
Figure S7. Wall-eyed stereo view of the ferroxidase centres of Hoch_EncFtn, and Pfc_EncFtn. 68 
A, Hoch_EncFtn ferroxidase centre, and B, Pfc_EncFtn ferroxidase centre. Protein residues are shown 69 
as sticks with bound iron ions shown as orange spheres. The 2mFo-DFc electron density map is shown 70 
as a blue mesh contoured at 1.5 σ and the anomalous difference map for Pfc_EncFtn is shown as an 71 
orange mesh and contoured at 5 σ. 72 
73 
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 74 
Figure S8. Native Mass Spectrometry of Hoch_EncFtn at pH 8.0 and pH 5.5. Native 75 
nanoelectrospray ionization (nESI) mass spectrometry of Hoch_His acquired in 100 mM ammonium 76 
acetate (pH 8.0 and pH 5.0). Hoch_His exists in various multimer conformations at pH 8.0 (A). 77 
Increasing pH to 5.5 (B) results in a shift to a higher molecular weight charge state distribution 78 
consistent with decameric structure (pink circles, 21+ to 25+). The appearance of an additional charge 79 
state (*) is also observed with increased pH which corresponds to a 20-mer assembly.  80 
 81 
 82 
 83 
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 84 
Figure S9. Progress curves of Ferroxidase activity of encapsulated ferritins in the presence of 85 
varying concentrations of zinc. Rru_StrepII (A, 10 μM monomer), Pfc_StrepII (B, 10 μM monomer), 86 
Hoch_StrepII (C, 10 μM monomer), were incubated with 50 μM FeSO4 (10 times molar equivalent 87 
Fe2+ per FOC) and various concentrations of ZnSO4 (0 μM – 10 μM – 25 μM – 40 μM – 50 μM – 70 88 
μM – 100 μM). Progress curves of the oxidation of Fe2+ to Fe3+ at 315 nm were recorded with a UV-89 
visible spectrophotometer over 1500 seconds. Data shown in A/B/C, represent three technical 90 
replicates per condition. Shaded areas represent standard deviation. Dotted black line represents 91 
protein assayed with 100 μM ZnSO4.2H2O as negative control. DOI: 10.6084/m9.figshare.7718879 92 
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